TrialPanorama/TrialPanorama-database huggingface dataset:
Study 32710888 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32710888 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34659642 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 34659642 — Surrogate Endpoint (SUR): Serum creatinine
Study 34659642 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 33151934 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33160147 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32281943 — Surrogate Endpoint (SUR): Blood pressure
Study 33290097 — Predictive Biomarker (PRD): TCP1 mRNA
Genes: TCP1; CCT1; CCTA
Study 32699918 — Surrogate Endpoint (SUR): Blood pressure
Study 37013278 — Surrogate Endpoint (SUR): Blood pressure
Study 35463794 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 35463794 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 35463794 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32506228 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35333599 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34301983 — Predictive Biomarker (PRD): OXTR mRNA
Genes: OXTR
Study 33588904 — Surrogate Endpoint (SUR): Blood pressure
Study 35945604 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 35945604 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 35562420 — Surrogate Endpoint (SUR): Blood pressure
Study 33839443 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 33485895 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 33485895 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33746216 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33746216 — Predictive Biomarker (PRD): SELENBP1 mRNA
Genes: SELENBP1; SBP
Study 33746216 — Surrogate Endpoint (SUR): Blood pressure
Study 34065571 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 34065571 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 32427113 — Surrogate Endpoint (SUR): Blood pressure
Study 35258025 — Surrogate Endpoint (SUR): Blood pressure
Study 35180850 — Surrogate Endpoint (SUR): Blood pressure
Study 35421233 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study 32767506 — Predictive Biomarker (PRD): LAT2 mRNA
Genes: LAT2; LAB; NTAL; WBS15; WBSCR15; WBSCR5; HSPC046
Study 32321387 — Surrogate Endpoint (SUR): Blood pressure
Study 32388868 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34908019 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study 34515194 — Surrogate Endpoint (SUR): Blood pressure
Study 32188697 — Surrogate Endpoint (SUR): Serum sodium
Study 32188697 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35339954 — Surrogate Endpoint (SUR): Blood pressure
Study 34601551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34601551 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 32060566 — Surrogate Endpoint (SUR): Bone mineral density
Study 33771659 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33771659 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 32602966 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 35294330 — Surrogate Endpoint (SUR): Blood pressure
Study 34914338 — Surrogate Endpoint (SUR): Forced vital capacity
Study 33065791 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33065791 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32176565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32176565 — Safety Biomarker (SAF): Interleukin 12
Study 32176565 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33289350 — Predictive Biomarker (PRD): FASN mRNA
Genes: FASN; FAS
Study 35565738 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 34272216 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34978861 — Surrogate Endpoint (SUR): Blood pressure
Study 33118603 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 35346485 — Surrogate Endpoint (SUR): Blood pressure
Study 35346485 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34312221 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 33919990 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 33919990 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 33919990 — Safety Biomarker (SAF): Reactive oxygen species
Study 33919990 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study 33331798 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33714712 — Surrogate Endpoint (SUR): Blood pressure
Study 34933343 — Predictive Biomarker (PRD): ETV6 mRNA
Genes: ETV6; TEL; TEL1
Study 34933343 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study 34933343 — Predictive Biomarker (PRD): TCF3 mRNA
Genes: TCF3; BHLHB21; E2A; ITF1
Study 34933343 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 34933343 — Predictive Biomarker (PRD): PAX5 mRNA
Genes: PAX5
Study 34933343 — Predictive Biomarker (PRD): MEF2D mRNA
Genes: MEF2D
Study 33606739 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 33606739 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 32232615 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32232615 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 32232615 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 32532356 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 32532356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32532356 — Surrogate Endpoint (SUR): Blood pressure
Study 32532356 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 32532356 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32532356 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 32532356 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33359194 — Surrogate Endpoint (SUR): Blood pressure
Study 35544149 — Predictive Biomarker (PRD): CTBS mRNA
Genes: CTBS; CTB
Study 35731529 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 35731529 — Predictive Biomarker (PRD): DSG3 mRNA
Genes: DSG3; CDHF6
Study 35290464 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36305696 — Surrogate Endpoint (SUR): Blood pressure
Study 33504897 — Predictive Biomarker (PRD): RETREG2 mRNA
Genes: RETREG2; C2orf17; FAM134A; MAG2
Study 33504897 — Predictive Biomarker (PRD): FAM178B mRNA
Genes: FAM178B; HSPC234
Study 33504897 — Predictive Biomarker (PRD): MVB12B mRNA
Genes: MVB12B; C9orf28; FAM125B
Study 33504897 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 33504897 — Predictive Biomarker (PRD): STMN3 mRNA
Genes: STMN3; SCLIP
Study 33504897 — Predictive Biomarker (PRD): PICK1 mRNA
Genes: PICK1; PRKCABP
Study 33504897 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32833564 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 32069236 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 34130026 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 36093393 — Predictive Biomarker (PRD): WAP four-disulfide core domain protein 2
Genes: WFDC2; HE4; WAP5
Study 36093393 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 34106990 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32170789 — Safety Biomarker (SAF): Fatty acid binding protein 1
Genes: FABP1; FABPL
Study 32170789 — Predictive Biomarker (PRD): SLC27A4 mRNA
Genes: SLC27A4; ACSVL4; FATP4
Study 35061634 — Predictive Biomarker (PRD): CPB1 mRNA
Genes: CPB1; CPB; PCPB
Study 32129101 — Surrogate Endpoint (SUR): Blood pressure
Study 33053283 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35714312 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study 34857029 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study 33120762 — Surrogate Endpoint (SUR): Forced vital capacity
Study 35756420 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33349862 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34204017 — Predictive Biomarker (PRD): PSG1 mRNA
Genes: PSG1; B1G1; PSBG1; PSGGA
Study 34204017 — Predictive Biomarker (PRD): PSG2 mRNA
Genes: PSG2; PSBG2
Study 32612272 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32840767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 32840767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33093222 — Predictive Biomarker (PRD): F2R mRNA
Genes: F2R; CF2R; PAR1; TR
Study 33093222 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 34642416 — Surrogate Endpoint (SUR): Blood pressure
Study 36210291 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 36210291 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 36210291 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32507152 — Surrogate Endpoint (SUR): Blood pressure
Study 32163578 — Surrogate Endpoint (SUR): Blood pressure
Study 32868662 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 35723774 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 35925503 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 32891136 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32891136 — Predictive Biomarker (PRD): BAG3 mRNA
Genes: BAG3; BIS
Study 35331230 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35331230 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 35331230 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33222470 — Surrogate Endpoint (SUR): Blood pressure
Study 33021585 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 33021585 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34889772 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 32006455 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 35554747 — Surrogate Endpoint (SUR): Blood pressure
Study 32791665 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32791665 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34598980 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study 36356410 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36356410 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 36356410 — Predictive Biomarker (PRD): Hormone receptor
Study 33427861 — Predictive Biomarker (PRD): FN1 mRNA
Genes: FN1; FN
Study 36042633 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36042633 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34238446 — Surrogate Endpoint (SUR): Blood pressure
Study 35574948 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 35699834 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35699834 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35699834 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 35699834 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 35699834 — Predictive Biomarker (PRD): Hormone receptor
Study 34670021 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36096771 — Safety Biomarker (SAF): Hyaluronic acid
Study 35109584 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 35395144 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 36038255 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36260464 — Surrogate Endpoint (SUR): Blood pressure
Study 33434447 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 33103453 — Predictive Biomarker (PRD): TBC1D1 mRNA
Genes: TBC1D1; KIAA1108
Study 33103453 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 34592862 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study 32481298 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 33849629 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 35940247 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34261990 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34261990 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 34261990 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 34261990 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 34261990 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34596156 — Surrogate Endpoint (SUR): Bone mineral density
Study 32394653 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 35418332 — Surrogate Endpoint (SUR): Blood pressure
Study 36267030 — Predictive Biomarker (PRD): NXF1 mRNA
Genes: NXF1; TAP
Study 35270396 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35270396 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35270396 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 35270396 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 35270396 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study 35270396 — Safety Biomarker (SAF): IL-6 and IL-10
Study 32742515 — Surrogate Endpoint (SUR): Blood pressure
Study 36124709 — Surrogate Endpoint (SUR): Blood pressure
Study 36277011 — Monitoring Biomarker (MOI): Procalcitonin
Study 36277011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36277011 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35683427 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 32209328 — Predictive Biomarker (PRD): SCN5A mRNA
Genes: SCN5A
Study 32068562 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 33242299 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 33242299 — Surrogate Endpoint (SUR): Bone mineral density
Study 32507157 — Surrogate Endpoint (SUR): Blood pressure
Study 34628013 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 36200545 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36200545 — Predictive Biomarker (PRD): CCS mRNA
Genes: CCS
Study 33895103 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 33895103 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study 32795341 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32795341 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34857215 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35858589 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 33780173 — Predictive Biomarker (PRD): SEPTIN6 mRNA
Genes: SEPTIN6; KIAA0128; SEP2; SEPT6
Study 33780173 — Predictive Biomarker (PRD): SEPTIN3 mRNA
Genes: SEPTIN3; SEP3; SEPT3
Study 36277008 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 36277008 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 36277008 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32384461 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33789133 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 33103448 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 35280748 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 33432790 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 33432790 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 32430452 — Surrogate Endpoint (SUR): Bone mineral density
Study 34310202 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32703216 — Surrogate Endpoint (SUR): Plasma ammonia
Study 35679902 — Safety Biomarker (SAF): Hyaluronic acid
Study 34409891 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 32870712 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 32870712 — Surrogate Endpoint (SUR): Bone mineral density
Study 33667228 — Surrogate Endpoint (SUR): Bone mineral density
Study 32996020 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study 32996020 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 35716046 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 33986125 — Predictive Biomarker (PRD): REG3A mRNA
Genes: REG3A; HIP; PAP; PAP1
Study 33986125 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34535469 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 35956334 — Predictive Biomarker (PRD): OSM mRNA
Genes: OSM
Study 35956334 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32030887 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 32756160 — Predictive Biomarker (PRD): LSS mRNA
Genes: LSS; OSC
Study 35089218 — Surrogate Endpoint (SUR): Serum creatinine
Study 35089218 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 32589686 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34008756 — Predictive Biomarker (PRD): CBX7 mRNA
Genes: CBX7
Study 34008756 — Predictive Biomarker (PRD): JADE2 mRNA
Genes: JADE2; KIAA0239; PHF15
Study 34008756 — Predictive Biomarker (PRD): IGF2BP3 mRNA
Genes: IGF2BP3; IMP3; KOC1; VICKZ3
Study 34008756 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study 34008756 — Predictive Biomarker (PRD): TICRR mRNA
Genes: TICRR; C15orf42
Study 34008756 — Predictive Biomarker (PRD): KIF4A mRNA
Genes: KIF4A; KIF4
Study 34008756 — Predictive Biomarker (PRD): PIMREG mRNA
Genes: PIMREG; CATS; FAM64A; RCS1
Study 34438327 — Predictive Biomarker (PRD): FMN1 mRNA
Genes: FMN1; FMN; LD
Study 34438327 — Predictive Biomarker (PRD): BRCA2
Genes: FAD; FAD1; BRCC2; XRCC11
Study 34438327 — Predictive Biomarker (PRD): ACAD9 mRNA
Genes: ACAD9
Study 34438327 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 32958820 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33476068 — Safety Biomarker (SAF): Hyaluronic acid
Study 32909059 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 32909059 — Predictive Biomarker (PRD): MYF6 mRNA
Genes: MYF6; BHLHC4; MRF4
Study 32909059 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32909059 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study 35529777 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 35529777 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35529777 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study 35529777 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 35011059 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32024400 — Surrogate Endpoint (SUR): Bone mineral density
Study 34530738 — Surrogate Endpoint (SUR): Blood pressure
Study 34825264 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2